Sinopharm Zhendong Pharmaceutical (300158.SZ) reported a net profit attributable to shareholders of 7.9313 million yuan in the first half of the year, a year-on-year decrease of 74.13%.

Wisdom Fortune Financial APP News, Zhendong Pharmaceutical (300158.SZ) released its 2025 interim report, during the reporting period, the company achieved operating income of 1.457 billion yuan, a decrease of 3.30% year-on-year. The net profit attributable to shareholders of the listed company was 7.9313 million yuan, a decrease of 74.13% year-on-year. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 8.1764 million yuan. The basic earnings per share was 0.0077 yuan.